Free Trial

This company has been marked as potentially delisted and may not be actively trading.

D8 (DEH) Competitors

D8 logo

DEH vs. ESTA, AVNS, SMTI, INGN, LAKE, ZJYL, AVR, MLSS, NTRB, and APT

Should you be buying D8 stock or one of its competitors? The main competitors of D8 include Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Anteris Technologies Global (AVR), Milestone Scientific (MLSS), Nutriband (NTRB), and Alpha Pro Tech (APT).

D8 vs.

Establishment Labs (NASDAQ:ESTA) and D8 (NYSE:DEH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking.

Establishment Labs received 119 more outperform votes than D8 when rated by MarketBeat users.

CompanyUnderperformOutperform
Establishment LabsOutperform Votes
119
61.98%
Underperform Votes
73
38.02%
D8N/AN/A

Establishment Labs presently has a consensus target price of $57.40, indicating a potential upside of 82.51%. Given Establishment Labs' stronger consensus rating and higher probable upside, research analysts plainly believe Establishment Labs is more favorable than D8.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
D8
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Establishment Labs had 10 more articles in the media than D8. MarketBeat recorded 10 mentions for Establishment Labs and 0 mentions for D8. Establishment Labs' average media sentiment score of 0.69 beat D8's score of -0.73 indicating that Establishment Labs is being referred to more favorably in the media.

Company Overall Sentiment
Establishment Labs Positive
D8 Negative

D8 has lower revenue, but higher earnings than Establishment Labs.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$166.03M5.46-$78.50M-$2.98-10.55
D8N/AN/A-$9.46MN/AN/A

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 65.4% of D8 shares are owned by institutional investors. 11.4% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

D8 has a net margin of 0.00% compared to Establishment Labs' net margin of -46.13%. D8's return on equity of 0.00% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-46.13% -184.55% -24.81%
D8 N/A N/A N/A

Summary

Establishment Labs beats D8 on 9 of the 13 factors compared between the two stocks.

Get D8 News Delivered to You Automatically

Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DEH vs. The Competition

MetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE Exchange
Market Cap$232.44M$8.59B$5.29B$18.42B
Dividend YieldN/A1.72%5.12%4.21%
P/E RatioN/A18.6621.7331.10
Price / SalesN/A70.67379.1626.58
Price / CashN/A19.6738.2217.54
Price / Book44.924.846.444.30
Net Income-$9.46M$284.66M$3.21B$1.02B

D8 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DEH
D8
N/A$5.39
-0.4%
N/A+1,853.1%$232.44MN/A0.003
ESTA
Establishment Labs
2.3682 of 5 stars
$31.32
flat
$57.40
+83.3%
-39.7%$903.46M$166.03M-12.14960Positive News
Gap Down
AVNS
Avanos Medical
3.2195 of 5 stars
$11.97
-3.5%
N/A-33.7%$550.66M$687.80M35.214,040
SMTI
Sanara MedTech
1.699 of 5 stars
$29.50
-1.5%
$48.50
+64.4%
-6.9%$262.61M$86.67M-29.8060
INGN
Inogen
3.0383 of 5 stars
$7.20
-1.6%
$7.00
-2.8%
-1.9%$193.59M$335.71M-3.201,030Short Interest ↓
Positive News
LAKE
Lakeland Industries
4.88 of 5 stars
$15.80
-0.9%
$27.00
+70.9%
-1.4%$150.08M$151.82M-175.561,800Analyst Forecast
Gap Down
ZJYL
Jin Medical International
N/A$0.86
-0.5%
N/A-76.9%$135.23M$23.50M0.00245News Coverage
AVR
Anteris Technologies Global
N/A$2.94
+14.0%
$16.50
+461.2%
N/A$105.91M$2.71M0.00138News Coverage
Positive News
MLSS
Milestone Scientific
2.0146 of 5 stars
$0.97
+6.1%
$1.25
+28.9%
+58.0%$75.56M$8.88M-13.8630Analyst Forecast
News Coverage
Gap Down
NTRB
Nutriband
2.9046 of 5 stars
$5.03
+1.4%
$13.00
+158.4%
+18.0%$55.86M$2.02M-7.0810Gap Down
APT
Alpha Pro Tech
N/A$4.41
+3.8%
N/A-29.2%$47.95M$57.84M11.92120

Related Companies and Tools


This page (NYSE:DEH) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners